News

Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting

by

Key opinion leader webinar to take place on June 5, 2023 at 8:00 a.m. ET SAN DIEGO and CALGARY, AB, May 26, 2023 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced that it will host a key opinion leader webinar to discuss data from the randomized phase 2 BRACELET-1 trial in HR+/HER2- metastatic breast … Read more

BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants

by

LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “Company”), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the “Units”), with each Unit consisting of one share of BIOLASE’s Series H Convertible Redeemable Preferred Stock, par value $0.001 per … Read more

Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations

by

FN Media Group Presents USA News Group News Commentary VANCOUVER, B.C., May 26, 2023 /PRNewswire/ — USA News Group  –  The world’s biggest cancer conference is set to roll again at American Society of Clinical Oncology (ASCO) 2023, with in-person attendance back in full swing and already 40,000 people registered by mid-May. Much like other years, there’s plenty … Read more

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors

by

TAMPERE, Finland, May 26, 2023 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability … Read more

Daewoong Pharmaceutical publica el mecanismo molecular de la bersiporocina como antifibrótico

by

-Daewoong Pharmaceutical publica el mecanismo molecular de la bersiporocina como antifibrótico en EMBO Molecular Medicine Elucidado el mecanismo molecular que subyace a la seguridad y eficacia de Bersiporocina La bersiporocina se encuentra actualmente en fase II de ensayo clínico para la fibrosis pulmonar idiopática SEÚL, Corea del Sur, 26 de mayo de 2023 /PRNewswire/ — Daewoong … Read more

Eric Schleicher, Founder and CEO of Constructive Realities Announced as Winner of OKdo’s Global ROCK Engineering Challenge

by

OKdo, RS, DesignSpark, and global partners, together with Wevolver, give a big thank you to all those who submitted innovative ideas and to the community for their participation LONDON, May 26, 2023 /PRNewswire/ — The ROCK Engineering Challenge invited engineers, developers, educators, inventors and entrepreneurs, to submit an idea based on the OKdo® ROCK single board … Read more

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

by

New York, May 26, 2023 /PRNewswire/ — Terran Biosciences (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has announced the publication of a PCT patent application covering what may be the first comprehensive salt and polymorph screens of the empathogens MDMA, (R)-MDMA, (S)-MDMA, MDEA (MDE), (S)-MDEA, (R)-MDEA, … Read more

Approval and publication of prospectus for the preferential Rights Issue

by

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS … Read more

Yili’s Subsidiary Westland Milk Products Holds Groundbreaking Ceremony for Lactoferrin Plant in New Zealand

by

HOKITIKA, New Zealand, May 26, 2023 /PRNewswire/ — On May 23, Yili’s subsidiary Westland Milk Products held a groundbreaking ceremony for the construction of its NZD 70 million (USD 42.58 million) lactoferrin plant at Hokitika, New Zealand. The ceremony was attended by New Zealand’s Trade, Export and Agriculture Minister and MP for West-Coast Tasman, Damien O’Connor; … Read more